Redefining 3D cell culture: Human methacryloyl platelet lysates hydrogels for reliable, consistent, and ethical applications.
Dias MM., Rufino AT., Vitorino R., Custódio CA., Mano JF.
Laboratory Study on Hip, published in Mater Today Bio (2026) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Laboratory Study
- Journal
- Mater Today Bio (2026)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 42473539
- DOI
- 10.1016/j.mtbio.2026.103443
Abstract (original English)
The transition to human-derived biomaterials is critical for advancing ethical and clinically relevant three-dimensional (3D) cell culture systems. In this study, we evaluate the performance of human methacryloyl platelet lysates (hPLMA), a xeno-free, human-derived hydrogel, benchmarking it against Matrigel, the gold standard in the field, and a widely used but animal-derived matrix with an unethical tumor origin. Human adipose-derived stem cells (hASCs) were encapsulated in both materials and cultured for 14 days. Both materials support high viability and proliferation for 7 days. However, hPLMA promotes consistent cell growth and intricate networks, while Matrigel induces rapid spreading, leading to massive cell clusters and ultimately the degradation of the hydrogel after 7 days. Although macrophage culture in both materials show low cytokine levels, the transcriptomic profile of hASCs in Matrigel reveal a constant high expression of immune-related genes, especially after 5 days. In contrast, hASCs in hPLMA have lower expression of immune response genes and higher expression of genes associated with cell migration, adhesion, and matrix organization, showing hPLMA's ability to mimic the natural cell environment. These results position hPLMA as a robust, xeno-free platform not only for 3D cell culture applications such as drug screening, organ-on-chip and tissue models, but al
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewPubMed
Adipose-Derived Stem Cells in Traumatic Brain Injury: A Systematic Review of Preclinical Studies.
Systematic Review on Neuroinflammation, published in Tissue Eng Regen Med (2026) — summary generated from the PubMed abstract.
- 2026
Tissue Eng Regen Med - Level AMeta-analysisPubMed
Comparative efficacy of different doses of mesenchymal stem cells derived from different tissue sources for knee osteoarthritis: a systematic review and network meta-analysis of randomized controlled trials.
Meta-analysis with a reported sample of 602 on Knee Osteoarthritis, Osteoarthritis, Chronic Inflammation, Immune Modulation, published in PeerJ (2026) — summary generated from the PubMed abstract.
- 2026
- n = 602
PeerJ - Level AMeta-analysisPubMed
Efficacy of Stem Cell-Derived Exosomes in Promoting Diabetic Foot Ulcer Healing: A Meta-Analysis of Preclinical Animal Studies.
Meta-analysis on Diabetic Foot, Chronic Wound, published in J Diabetes Res (2026) — summary generated from the PubMed abstract.
- 2026
J Diabetes Res - Level ASystematic ReviewEurope PMC
The Role of Exosome-miRNA as Biomarkers of Alzheimer's Disease: A Systematic Review of Case-Control and Longitudinal Studies
Systematic Review with a reported sample of 3046 on Neuroinflammation, published in Actas Esp Psiquiatr (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3046
Actas Esp Psiquiatr - Level AMeta-analysisEurope PMC
Exosome-based therapy for epilepsy: a systematic review and meta-analysis of preclinical studies
Meta-analysis on Neuroinflammation, published in Front Neurosci (2026) — summary generated from the PubMed abstract.
- 2026
Front Neurosci - Level AMeta-analysisEurope PMC
Efficacy of stem cell therapy for achilles tendon rupture: a systematic review and meta-analysis based on animal studies
Meta-analysis on Tendon Injury, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.
- 2026
Front Bioeng Biotechnol